The cancer drugs that could improve survival rates if given to patients in the morning

A study has found that people with terminal lung or skin cancers lived twice as long if they received ­immunotherapy drugs - at the start of the day instead of after lunchtime.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news